The use and impact of bevacizumab (Avastin) for the treatment of metastatic colorectal cancer treatment in Australia
收藏DataCite Commons2022-07-26 更新2025-04-17 收录
下载链接：
http://hdl.handle.net/1959.4/004_279
下载链接
链接失效反馈官方服务：
资源简介：
This project was established to conduct a long-term evaluation of the way in which bevacizumab (Avastin) is used to treat metastatic colorectal cancer in the real world clinical setting. Bevacizumab became available under the Pharmaceutical Benefits Scheme (PBS) in July 2009. This study has access to the PBS history of all patients prescribed bevacizumab since its PBS-subsidy and has approval for annual data updates until 2016. Originating source(s): Medicare Australia [Pharmaceutical Benefits Scheme] [Patient/Medicare enrolment data]
提供机构：
UNSW Sydney
创建时间：
2021-11-30
